Analysis reportAll specifications met
Retatrutide 20mg
Peptide Stock ref. PSV-2609-RT20-02
Purity99.83%RP-HPLC, 214 nm
Content per vial20.74 mg103.7% of 20 mg label claim
IdentityConfirmedLC-MS/MS
Test results
| Test | Specification | Result | Outcome |
|---|---|---|---|
| Identity (LC-MS/MS) | Retatrutide | Retatrutide | Pass |
| Content (HPLC quantitation) | — | 20.74 mg (103.7% of claim) | Pass |
| Overall purity (RP-HPLC 214 nm) | — | 99.83% | Pass |
About this report
- Sample received by the lab 31 August 2026; report issued 2 September 2026.
- Appearance as received: white lyophilised powder.
- Results relate to the sample tested. For laboratory research use only.